Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(302)
•••
Comment by jojomarchon Jan 24, 2020 11:49am
90 Views
Post# 30594627

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How about some really good news TLT . TIA

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How about some really good news TLT . TIA
LaserStock29 wrote: Outpatient treatment was mentioned at the agm as part of the technological advantage. Further lessening hospital load. Increasing the device division as private clinics could in effect purchase the laser device to treat. Sigh... Lol. If only we partnered with a global power we would be able to upscale properly
investclub wrote: goldn1 wrote
invest: Even if ppl have access, only very few doctors know how to use it... once tld replaces big as the standard of care, that will change. G1


If Theralase were to send TDL-1433 on a humanitarian effort or to a hospital new to the treatment it would also be accompanied with equipment plus trained people. goldn1 I remember reading that at some point this treatment could at one point be done at clinics because of its simplicity however it may also have just been another posters thoughts! 
 



If only we partnered with a global power we would be able to upscale properly

Yes i fully agree and other posters such  as  LaserStock also agree . Maybe the corporate development division of TLT can look in to this ...it would be fun IMO .


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities